Ocumension Therapeutics (1477.HK) HKSE
5.70
-0.17(-2.90%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.70
-0.17(-2.90%)
Currency In HKD
| Market Cap | 5.26B |
| Enterprise Value | 5.04B |
| P/E Ratio | -24.55 |
| PEG Ratio | -0.4 |
| Price/Sales Ratio | 4.91 |
| Price/Book Ratio | 1.06 |
| Enterprise/Revenue | 4.65 |
| Enterprise/EBITDA | -124.78 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.2 |
| Operating Margin | -0.2 |
| Return On Assets | -0.04 |
| Return On Equity | -0.04 |
| Revenue | 804.35M |
| Revenue/Share | 1.01 |
| Gross Profit | 360.92M |
| EBITDA | -29.95M |
| Net Income | -158.82M |
| Diluted EPS | -0.2 |
| Total Cash | 402.63M |
| Total Cash/Share | 0.51 |
| Total Debt | 187.62M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 3.7 |
| Book Value Per Share | 4.64 |
| 52-Week Change | -27.11 |
| 52-Week High | 12.23 |
| 52-Week Low | 5.67 |
| Moving Average 50 Days | 7.28 |
| Moving Average 200 Days | 7.89 |
| Average Volume | 867,882 |
| Shares Outstanding | 803.92M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |